Edgestream Partners L.P. purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 7,608 shares of the health services provider's stock, valued at approximately $568,000.
Other institutional investors have also recently made changes to their positions in the company. Atria Investments Inc bought a new stake in Maximus in the third quarter worth about $244,000. Covestor Ltd lifted its stake in Maximus by 913.0% in the third quarter. Covestor Ltd now owns 1,246 shares of the health services provider's stock worth $116,000 after purchasing an additional 1,123 shares during the last quarter. Crossmark Global Holdings Inc. lifted its stake in Maximus by 9.8% in the third quarter. Crossmark Global Holdings Inc. now owns 4,152 shares of the health services provider's stock worth $387,000 after purchasing an additional 369 shares during the last quarter. Versor Investments LP lifted its stake in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after purchasing an additional 5,789 shares during the last quarter. Finally, Entropy Technologies LP bought a new stake in Maximus in the third quarter worth about $214,000. Institutional investors own 97.21% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on MMS. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
Get Our Latest Report on Maximus
Insider Buying and Selling at Maximus
In other Maximus news, CEO Bruce Caswell purchased 3,500 shares of the firm's stock in a transaction on Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.
Maximus Stock Performance
NYSE MMS traded up $0.22 on Friday, reaching $67.06. 457,007 shares of the company's stock traded hands, compared to its average volume of 481,849. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of 14.42 and a beta of 0.71. The stock has a 50 day moving average price of $72.01 and a 200-day moving average price of $79.39. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.
Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date was Friday, February 14th. Maximus's dividend payout ratio is presently 25.81%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.